COMMUNIQUÉS West-GlobeNewswire

Veloxis Secures USD 60M in Debt Financing

14/02/2018 - 21:36

Company Release no. 01/2018 To: NASDAQ Copenhagen A/S 14 February 2018 Veloxis Secures USD 60M in Debt Financing Cary, NC, February 14, 2018 -- Veloxis Pharmaceuticals A/S (OMX:VELO), a specialty pharmaceutical company [...]

Cannabis Wheaton Income Corp. Extends Warrant Expiry Until February 20, 2018

14/02/2018 - 21:31

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

Nextech Announces Key Expansions to Executive Team

14/02/2018 - 20:56

TAMPA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, today announces two major updates to its executive leadership [...]

Adventist Health Announces Retirement of CFO Jack Wagner

14/02/2018 - 18:20

ROSEVILLE, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii— today announced the planned [...]

MJ Biotech, Inc Corporate Update

14/02/2018 - 18:19

CHEYENNE, Wyo., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) is in the process of completing its acquisition of Zen Hero, Inc. with the expectation of closing this [...]

Envigo Announces Termination of Transaction Agreement with Avista Healthcare Public Acquisition Corp.

14/02/2018 - 17:34

EAST MILLSTONE, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Envigo International Holdings, Inc. ("Envigo"), a leading provider of nonclinical contract research services and research models, announced today that the [...]

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing

14/02/2018 - 17:23

FIT Biotech Oy Company release February 14, 2018 at 6.00 pm EET FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

14/02/2018 - 16:45

FIT Biotech Oy Company release February 14, 2018 at 5:45 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]

The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

14/02/2018 - 16:35

WASHINGTON, D.C., Feb. 14, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced its annual Cell & Gene Therapy Investor Day will take place April 17, 2018 in New York City. This [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

14/02/2018 - 16:31

FIT Biotech Oy Company release February 14, 2018 at 5:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Emerald Health Therapeutics Closes $18 Million Prospectus Sale

14/02/2018 - 15:52

VICTORIA, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ("Emerald" or the “Company”) has closed its prospectus sale (the “Offering”) to a single Canadian [...]

Tauriga Sciences Inc. Gains Exposure to Electric Vehicle Infrastructure Market Segment Through Strategic $191,250 USD Transaction

14/02/2018 - 15:40

NEW YORK, NY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

14/02/2018 - 15:31

BUENA, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

Sienna Biopharmaceuticals Announces First Patient Dosed in First-in-Human Trial of Topical SNA-125

14/02/2018 - 15:05

-- Trial to Enroll Approximately 15 Patients with Psoriasis -- Top-Line Results Expected in Third Quarter of 2018 WESTLAKE VILLAGE, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA [...]

Patient Home Monitoring Announces Plans to Change Name; Appoints New CFO in Advance of Acquisition Strategy

14/02/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]

Oncobiologics Reports First Quarter Fiscal Year 2018 Results

14/02/2018 - 15:00

CRANBURY, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) today reported financial results and business highlights for its first fiscal quarter ended December 31, 2017. Oncobiologics had a net [...]

Burcon Announces Completion of Rights Offering

14/02/2018 - 14:32

VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon " or the " Company ") is pleased to announce the completion of its rights offering (the [...]

MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients

14/02/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell

14/02/2018 - 14:30

TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “ Company ” or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that the Company has received approval from the [...]